National Institute for health and Care Excellence (NICE)
- Advice for secondary care (link)
- Advice for primary care (link)
- Advice for community based health, social, mental health and ambulance service (link)
National Institute for Health Research (NIHR)
- Priority trials (link)
Specialist Pharmacy Service – COVID-19 resources
- Summary of COVID-19 medicines guidance from professional and government bodies
- Allergy and immunology (link)
- Anaesthesia and pain (link)
- Cancer (link)
- Cardiovascular system disorders (link)
- Critical care (link)
- Diabetes (link)
- Endocrine system disorders (link)
- Eyes and vision (link)
- Family planning (link)
- Gastrointestinal disorders (link)
- Haematological disorders (link)
- Infection and infectious diseases (link)
- Later life (link)
- Learning disabilities (link)
- Mental health and illness (link)
- Musculo-skeletal disorders (link)
- Neurological disorders (link)
- Nutritional and inherited metabolic disorders (link)
- Obstetrics and gynaecology (link)
- Paediatric and neonatal medicine (link)
- Palliative and End of Life Care (link)
- Policy, Commissioning and Managerial (link)
- Renal and urologic disorders (link)
- Respiratory disorders (link)
- Skin disorders (link)
- Stroke (link)
- Surgery (link)
- Wounds and injuries (link)
- Mental health
- Drug monitoring
- Azathioprine, leflunomide, mercatopurine, and methotrexate, drug monitoring in primary care during COVID-19 (link)
- Guidance on the management of drugs requiring monitoring during COVID-19 (link)
- Drug monitoring: factors to consider during Covid-19 (link)
- Ciclosporin drug monitoring in primary care during COVID-19 (link)
- Clozapine drug monitoring during COVID-19 for stable adult patients (link)
- Hydroxychloroquine drug monitoring during COVID-19 (link)
- Lithium drug monitoring during COVID-19 for stable adult patients (link)
- Penicillamine drug monitoring in primary care during COVID-19 (link)
- Sulfasalazine drug monitoring in primary care during COVID-19 (link)
- Injectable medicines
- General
- Intensive care
- Syringe compatibility information